San Luis Wealth Advisors LLC Purchases New Shares in CVS Health Corporation $CVS

Key Points

• San Luis Wealth Advisors LLC acquired approximately 9,767 shares of CVS Health Corporation, valued at about $674,000, during the second quarter.
• CVS Health's recent earnings report showed an EPS of $1.81, exceeding analysts' estimates, along with revenues of $98.92 billion, representing an increase of 8.4% year-over-year.
• CVS Health is scheduled to pay a $0.665 quarterly dividend on November 3rd, with a current dividend yield of 3.5% and a payout ratio of 74.30%.

San Luis Wealth Advisors LLC purchased a new stake in CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 9,767 shares of the pharmacy operator's stock, valued at approximately $674,000.

A number of other institutional investors have also bought and sold shares of CVS. Bell Investment Advisors Inc boosted its holdings in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock valued at $31,000 after purchasing an additional 248 shares during the period. Roxbury Financial LLC increased its position in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 202 shares during the period. ORG Partners LLC lifted its stake in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 377 shares during the period. Saudi Central Bank purchased a new stake in shares of CVS Health in the first quarter valued at about $34,000. Finally, Livelsberger Financial Advisory acquired a new stake in CVS Health in the second quarter valued at approximately $35,000. Institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CVS. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Sunday, September 21st. Morgan Stanley boosted their target price on CVS Health from $80.00 to $82.00 and gave the company an "overweight" rating in a research note on Friday, August 1st. Sanford C. Bernstein raised their target price on CVS Health from $72.00 to $77.00 and gave the company a "market perform" rating in a report on Friday, September 5th. Bernstein Bank cut their target price on CVS Health from $78.00 to $72.00 and set a "market perform" rating on the stock in a research note on Wednesday, July 16th. Finally, Wolfe Research increased their price objective on CVS Health from $80.00 to $85.00 and gave the stock an "outperform" rating in a report on Monday, September 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $78.25.

CVS Health Stock Performance

NYSE:CVS opened at $75.80 on Friday. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $77.34. The firm's fifty day moving average price is $69.13 and its 200 day moving average price is $66.99. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The firm has a market cap of $96.14 billion, a price-to-earnings ratio of 21.17, a price-to-earnings-growth ratio of 0.84 and a beta of 0.62.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm's revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health's dividend payout ratio is presently 74.30%.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.